Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

When we have separated the group of patients according to stage of DKD in patients with normo, micro, and macroalbuminuria, there are lower levels of 25(OH)D in the last when compared to the first two groups (26.7 ± 6.2, 24.8 ± 7.0, and 15.9 ± 7.6 ng/ml; p < 0.05, respectively).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D on Early Stages of Diabetic Kidney Disease: A Cross-sectional Study in Patients with Type 1 Diabetes Mellitus

Source: Article title.

Patients were recruited from Endocrinology Division of the Federal University of Pará, included 37 T1DM with normal GFR (≥90 ml/min/1.73 m2) () and 36 controls with normal serum creatinine and without comorbidities.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D on Early Stages of Diabetic Kidney Disease: A Cross-sectional Study in Patients with Type 1 Diabetes Mellitus

Cross-sectional study · Frontiers in Endocrinology · 2016

Original publication title

Vitamin D on Early Stages of Diabetic Kidney Disease: A Cross-sectional Study in Patients with Type 1 Diabetes Mellitus

João Soares Felício; Rafael Mendonça Luz; Franciane Trindade Cunha de Melo; Fabricio de Souza Resende; Alana Ferreira de Oliveira; Amanda Soares Peixoto; João Felício Abrahão Neto; Carolina Tavares Carvalho; Denisson Dias da Silva; Marcia Costa dos Santos; Natércia Neves Marques de Queiroz; Manuela Nascimento de Lemos; Elizabeth Sumi Yamada; Karem Miléo Felício

Copyright © 2016 Felício, Luz, de Melo, de Souza Resende, de Oliveira, Peixoto, Abrahão Neto, Carvalho, da Silva, Santos, de Queiroz, de Lemos, Yamada and Felício.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our data suggest an association between reduced levels of VD and the presence and severity of DKD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The purpose of study was to evaluate the existence of an association between low levels of VD and the presence and degree of DKD in T1DM.

Source: Objective

Abstract: What methods does the paper describe?

We performed a cross-sectional study, between November 2014 and December 2015. Levels of 25(OH)D and albuminuria were analyzed in 37 patients with T1DM and normal glomerular filtration rate. Thirty-six subjects were evaluated as a control group.

Source: Patients and methods

Abstract: Context

Genetic and environmental factors are involved in the pathogenesis of type 1 diabetes mellitus (T1DM), and vitamin D (VD) deficiency appears as a candidate to risk factor for developing diabetic kidney disease (DKD).

Source: Context

Abstract: Results

Patients with T1DM and hypovitaminosis D had higher levels of albuminuria compared to those with normal VD levels [albuminuria (log10) = 1.92 vs. 1.44; p < 0.05]. When we have separated the group of patients according to stage of DKD in patients with normo, micro, and macroalbuminuria, there are lower levels of 25(OH)D in the last when compared to the first two groups (26.7 ± 6.2, 24.8 ± 7.0, and 15.9 ± 7.6 ng/ml; p < 0.05, respectively).

In T1DM group, we have found correlations between VD levels and both albuminuria and DKD stages (r = −0.5; p < 0.01 and r = −0.4; p < 0.05, respectively). A simple linear regression model, with albuminuria as the dependent variable and VD as an independent variable, showed r2 = 0.2 and p < 0.01.

Source: Results

Abstract: Conclusion

Our data suggest an association between reduced levels of VD and the presence and severity of DKD.

Source: Conclusion
Authors’ abstract

Context

Genetic and environmental factors are involved in the pathogenesis of type 1 diabetes mellitus (T1DM), and vitamin D (VD) deficiency appears as a candidate to risk factor for developing diabetic kidney disease (DKD).

Objective

The purpose of study was to evaluate the existence of an association between low levels of VD and the presence and degree of DKD in T1DM.

Patients and methods

We performed a cross-sectional study, between November 2014 and December 2015. Levels of 25(OH)D and albuminuria were analyzed in 37 patients with T1DM and normal glomerular filtration rate. Thirty-six subjects were evaluated as a control group.

Results

Patients with T1DM and hypovitaminosis D had higher levels of albuminuria compared to those with normal VD levels [albuminuria (log10) = 1.92 vs. 1.44; p < 0.05]. When we have separated the group of patients according to stage of DKD in patients with normo, micro, and macroalbuminuria, there are lower levels of 25(OH)D in the last when compared to the first two groups (26.7 ± 6.2, 24.8 ± 7.0, and 15.9 ± 7.6 ng/ml; p < 0.05, respectively).

In T1DM group, we have found correlations between VD levels and both albuminuria and DKD stages (r = −0.5; p < 0.01 and r = −0.4; p < 0.05, respectively). A simple linear regression model, with albuminuria as the dependent variable and VD as an independent variable, showed r2 = 0.2 and p < 0.01.

Conclusion

Our data suggest an association between reduced levels of VD and the presence and severity of DKD.

Publication and source details

Original title: Vitamin D on Early Stages of Diabetic Kidney Disease: A Cross-sectional Study in Patients with Type 1 Diabetes Mellitus

João Soares Felício; Rafael Mendonça Luz; Franciane Trindade Cunha de Melo; Fabricio de Souza Resende; Alana Ferreira de Oliveira; Amanda Soares Peixoto; João Felício Abrahão Neto; Carolina Tavares Carvalho; Denisson Dias da Silva; Marcia Costa dos Santos; Natércia Neves Marques de Queiroz; Manuela Nascimento de Lemos; Elizabeth Sumi Yamada; Karem Miléo Felício

Frontiers in Endocrinology · 2016

Edited by: Gaetano Santulli, Columbia University, USA

Reviewed by: Melissa Orlandin Premaor, Universidade Federal de Santa Maria, Brazil; Angela Lombardi, Albert Einstein College of Medicine, USA

*Correspondence: João Soares Felício, felicio.bel@terra.com.br

Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology

Copyright © 2016 Felício, Luz, de Melo, de Souza Resende, de Oliveira, Peixoto, Abrahão Neto, Carvalho, da Silva, Santos, de Queiroz, de Lemos, Yamada and Felício.2016Felício, Luz, de Melo, de Souza Resende, de Oliveira, Peixoto, Abrahão Neto, Carvalho, da Silva, Santos, de Queiroz, de Lemos, Yamada and Felíciohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:45:02.575690+00:00

DOI: 10.3389/fendo.2016.00149 · PMC5151807